Pharmacokinetics and pharmacodynamics of a high concentration of buprenorphine (Simbadol) in conscious horses after subcutaneous administration
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.1016/j.vaa.2021.02.005 http://hdl.handle.net/11449/207660 |
Resumo: | Objective: To determine the pharmacokinetics and pharmacodynamics of high-concentration formulation of buprenorphine (1.8 mg mL–1; Simbadol) following subcutaneous (SC) administration in horses. Study design: Prospective, randomized, crossover trial. Animals: A group of six healthy adult horses weighing 521–602 kg. Methods: On three occasions, Simbadol (0.005 mg kg–1; treatment S5), (0.0025 mg kg–1; treatment S2.5) or saline (treatment SAL) were administered SC at least 7 days apart in random order. Electrical nociceptive threshold (ENT) measured on the neck region, physiologic variables, locomotor activity, degree of restlessness and presence of excitatory signs were measured at baseline and for up to 48 hours after injection. Blood was collected for pharmacokinetic analysis at the same time intervals and plasma buprenorphine concentration (Cp) measured using liquid chromatography–tandem mass spectrometry. Results: Buprenorphine was quantifiable in all horses from 15 minutes after administration up to 8–12 hours. ENT was significantly increased in treatment S2.5 compared with treatment SAL at 0.75–6 hours after treatment. Increase in locomotor activity and compulsive behavior were recorded in all horses after Simbadol, and degree of restlessness was significantly higher in treatment S5 than SAL for a sustained time. Gastrointestinal motility significantly decreased in all horses after Simbadol and returned to baseline by 16 hours after treatment. Conclusions and clinical relevance: In horses, SC Simbadol was rapidly absorbed and Cp decreased rapidly. Side effects commonly seen in horses after opioids were observed in both Simbadol treatments, but degree of opioid-induced excitement lasted significantly longer in treatment S5. Simbadol (0.0025 mg kg–1) SC has the potential to be used clinically to treat pain in horses. However, at this dose, duration of antinociceptive effects was not longer than that reported for conventional buprenorphine, and side effects, including reduction in gastrointestinal motility and increased locomotor activity, were documented. |
id |
UNSP_8e2781ff6d43ebcbcd9d4011f1b9c359 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/207660 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Pharmacokinetics and pharmacodynamics of a high concentration of buprenorphine (Simbadol) in conscious horses after subcutaneous administrationanalgesiabuprenorphineelectrical nociceptive thresholdequineopioidsSimbadolObjective: To determine the pharmacokinetics and pharmacodynamics of high-concentration formulation of buprenorphine (1.8 mg mL–1; Simbadol) following subcutaneous (SC) administration in horses. Study design: Prospective, randomized, crossover trial. Animals: A group of six healthy adult horses weighing 521–602 kg. Methods: On three occasions, Simbadol (0.005 mg kg–1; treatment S5), (0.0025 mg kg–1; treatment S2.5) or saline (treatment SAL) were administered SC at least 7 days apart in random order. Electrical nociceptive threshold (ENT) measured on the neck region, physiologic variables, locomotor activity, degree of restlessness and presence of excitatory signs were measured at baseline and for up to 48 hours after injection. Blood was collected for pharmacokinetic analysis at the same time intervals and plasma buprenorphine concentration (Cp) measured using liquid chromatography–tandem mass spectrometry. Results: Buprenorphine was quantifiable in all horses from 15 minutes after administration up to 8–12 hours. ENT was significantly increased in treatment S2.5 compared with treatment SAL at 0.75–6 hours after treatment. Increase in locomotor activity and compulsive behavior were recorded in all horses after Simbadol, and degree of restlessness was significantly higher in treatment S5 than SAL for a sustained time. Gastrointestinal motility significantly decreased in all horses after Simbadol and returned to baseline by 16 hours after treatment. Conclusions and clinical relevance: In horses, SC Simbadol was rapidly absorbed and Cp decreased rapidly. Side effects commonly seen in horses after opioids were observed in both Simbadol treatments, but degree of opioid-induced excitement lasted significantly longer in treatment S5. Simbadol (0.0025 mg kg–1) SC has the potential to be used clinically to treat pain in horses. However, at this dose, duration of antinociceptive effects was not longer than that reported for conventional buprenorphine, and side effects, including reduction in gastrointestinal motility and increased locomotor activity, were documented.Veterinary Medical Teaching Hospital School of Veterinary Medicine University of California DavisDepartment of Surgical and Radiological Sciences School of Veterinary Medicine University of California DavisKL Maddy Equine Analytical Chemistry Laboratory School of Veterinary Medicine University of California DavisDepartment of Veterinary Surgery and Anesthesiology Faculdade de Medicina Veterinária e Zootecnia Universidade Estadual Paulista - UNESPDepartment of Veterinary Surgery and Anesthesiology Faculdade de Medicina Veterinária e Zootecnia Universidade Estadual Paulista - UNESPUniversity of California DavisUniversidade Estadual Paulista (Unesp)Flynn, HarrietCenani, AlessiaBrosnan, Robert J.DiMaio Knych, Heather K.de Araujo Aguiar, Antonio J. [UNESP]2021-06-25T10:58:52Z2021-06-25T10:58:52Z2021-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1016/j.vaa.2021.02.005Veterinary Anaesthesia and Analgesia.1467-29951467-2987http://hdl.handle.net/11449/20766010.1016/j.vaa.2021.02.0052-s2.0-85104932892Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengVeterinary Anaesthesia and Analgesiainfo:eu-repo/semantics/openAccess2021-10-23T17:45:55Zoai:repositorio.unesp.br:11449/207660Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462021-10-23T17:45:55Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Pharmacokinetics and pharmacodynamics of a high concentration of buprenorphine (Simbadol) in conscious horses after subcutaneous administration |
title |
Pharmacokinetics and pharmacodynamics of a high concentration of buprenorphine (Simbadol) in conscious horses after subcutaneous administration |
spellingShingle |
Pharmacokinetics and pharmacodynamics of a high concentration of buprenorphine (Simbadol) in conscious horses after subcutaneous administration Flynn, Harriet analgesia buprenorphine electrical nociceptive threshold equine opioids Simbadol |
title_short |
Pharmacokinetics and pharmacodynamics of a high concentration of buprenorphine (Simbadol) in conscious horses after subcutaneous administration |
title_full |
Pharmacokinetics and pharmacodynamics of a high concentration of buprenorphine (Simbadol) in conscious horses after subcutaneous administration |
title_fullStr |
Pharmacokinetics and pharmacodynamics of a high concentration of buprenorphine (Simbadol) in conscious horses after subcutaneous administration |
title_full_unstemmed |
Pharmacokinetics and pharmacodynamics of a high concentration of buprenorphine (Simbadol) in conscious horses after subcutaneous administration |
title_sort |
Pharmacokinetics and pharmacodynamics of a high concentration of buprenorphine (Simbadol) in conscious horses after subcutaneous administration |
author |
Flynn, Harriet |
author_facet |
Flynn, Harriet Cenani, Alessia Brosnan, Robert J. DiMaio Knych, Heather K. de Araujo Aguiar, Antonio J. [UNESP] |
author_role |
author |
author2 |
Cenani, Alessia Brosnan, Robert J. DiMaio Knych, Heather K. de Araujo Aguiar, Antonio J. [UNESP] |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
University of California Davis Universidade Estadual Paulista (Unesp) |
dc.contributor.author.fl_str_mv |
Flynn, Harriet Cenani, Alessia Brosnan, Robert J. DiMaio Knych, Heather K. de Araujo Aguiar, Antonio J. [UNESP] |
dc.subject.por.fl_str_mv |
analgesia buprenorphine electrical nociceptive threshold equine opioids Simbadol |
topic |
analgesia buprenorphine electrical nociceptive threshold equine opioids Simbadol |
description |
Objective: To determine the pharmacokinetics and pharmacodynamics of high-concentration formulation of buprenorphine (1.8 mg mL–1; Simbadol) following subcutaneous (SC) administration in horses. Study design: Prospective, randomized, crossover trial. Animals: A group of six healthy adult horses weighing 521–602 kg. Methods: On three occasions, Simbadol (0.005 mg kg–1; treatment S5), (0.0025 mg kg–1; treatment S2.5) or saline (treatment SAL) were administered SC at least 7 days apart in random order. Electrical nociceptive threshold (ENT) measured on the neck region, physiologic variables, locomotor activity, degree of restlessness and presence of excitatory signs were measured at baseline and for up to 48 hours after injection. Blood was collected for pharmacokinetic analysis at the same time intervals and plasma buprenorphine concentration (Cp) measured using liquid chromatography–tandem mass spectrometry. Results: Buprenorphine was quantifiable in all horses from 15 minutes after administration up to 8–12 hours. ENT was significantly increased in treatment S2.5 compared with treatment SAL at 0.75–6 hours after treatment. Increase in locomotor activity and compulsive behavior were recorded in all horses after Simbadol, and degree of restlessness was significantly higher in treatment S5 than SAL for a sustained time. Gastrointestinal motility significantly decreased in all horses after Simbadol and returned to baseline by 16 hours after treatment. Conclusions and clinical relevance: In horses, SC Simbadol was rapidly absorbed and Cp decreased rapidly. Side effects commonly seen in horses after opioids were observed in both Simbadol treatments, but degree of opioid-induced excitement lasted significantly longer in treatment S5. Simbadol (0.0025 mg kg–1) SC has the potential to be used clinically to treat pain in horses. However, at this dose, duration of antinociceptive effects was not longer than that reported for conventional buprenorphine, and side effects, including reduction in gastrointestinal motility and increased locomotor activity, were documented. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-06-25T10:58:52Z 2021-06-25T10:58:52Z 2021-01-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.vaa.2021.02.005 Veterinary Anaesthesia and Analgesia. 1467-2995 1467-2987 http://hdl.handle.net/11449/207660 10.1016/j.vaa.2021.02.005 2-s2.0-85104932892 |
url |
http://dx.doi.org/10.1016/j.vaa.2021.02.005 http://hdl.handle.net/11449/207660 |
identifier_str_mv |
Veterinary Anaesthesia and Analgesia. 1467-2995 1467-2987 10.1016/j.vaa.2021.02.005 2-s2.0-85104932892 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Veterinary Anaesthesia and Analgesia |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1803649693072228352 |